Designer Babies: Rogue Science or Future Option?
By Dolli Player and Alicia Matsuura,
The Daily Universe [Cites CGS' Marcy Darnovsky]
| 02. 18. 2020
In the early 2000s, genome editing seemed like the answer to parents who carried latent genes that could result in birth defects, future illnesses or poor quality of life for their potential children. But the technology was still unrefined and expensive. It seemed like it was too far off in the future — a science-fiction-inspired solution to real-world problems.
It wasn’t until the discovery of the CRISPR-Cas9 combination in 2013 that the conversation among scientists changed from “it’s impossible” to “should it be possible?”
Before being able to grasp the meaning of the term “designer babies,” it’s important to understand the building blocks of the system that makes it possible.
The scientific process of creating these possible “designer babies” is called genome editing. A genome is present in every living organism, and it encodes all the messages and instructions of that organism’s DNA sequence. This sequence makes up the characteristics and functions of that organism. CRISPR-cas9 and genome editing change those sequences, which in turn changes the message and the output of those cells.
In scientific terms, CRISPR, which stands...
Related Articles
By Carl Zimmer, The New York Times | 10.20.2026
For the first time, scientists say they have used viruses designed by artificial intelligence to treat a human patient.
Researchers announced on Tuesday that they had administered the virus, known as a phage, to a patient suffering from a deadly...
By Noah Fromson, HealthLab | 10.19.2026
Gene therapy is no longer the future of medicine — it’s reality. Treatments that replace, silence or edit genes are already changing clinical care.
There are more than 6,000 rare genetic disorders but only a fraction currently have treatable targets...
By Roxanne Khamsi, The Atlantic | 10.16.2026
In recent months, news came out about several distressing cases that have underscored the risks of gene therapy, which delivers DNA to a patient’s cells to treat disease. All of these cases have one thing in common that’s not apparent...
By Rebecca Roberts, The Scientist | 10.11.2026
Heritable genome editing in human embryos is once again under intense scrutiny after the publication of an opinion piece in Trends in Genetics at the end of last month.1 In the paper, Cathy Tie, the founder and chief...